Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Shares Outstanding (2016 - 2025)

Bio Key International's Shares Outstanding history spans 16 years, with the latest figure at $7.3 million for Q3 2025.

  • For Q3 2025, Shares Outstanding rose 135.21% year-over-year to $7.3 million; the TTM value through Sep 2025 reached $7.3 million, up 135.21%, while the annual FY2024 figure was $3.7 million, 259.76% up from the prior year.
  • Shares Outstanding for Q3 2025 was $7.3 million at Bio Key International, up from $6.8 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $8.5 million in Q3 2022 and bottomed at $478475.0 in Q4 2021.
  • The 5-year median for Shares Outstanding is $3.7 million (2024), against an average of $4.4 million.
  • The largest annual shift saw Shares Outstanding tumbled 93.88% in 2021 before it skyrocketed 274.48% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $478475.0 in 2021, then increased by 15.52% to $552739.0 in 2022, then soared by 86.85% to $1.0 million in 2023, then soared by 259.76% to $3.7 million in 2024, then skyrocketed by 96.84% to $7.3 million in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Shares Outstanding are $7.3 million (Q3 2025), $6.8 million (Q2 2025), and $5.8 million (Q1 2025).